- Home
- CIK vs RPID Comparison
CIK vs RPID Comparison
Compare CIK & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIK
- RPID
- Stock Information
- Founded
- CIK 1987
- RPID 2006
- Country
- CIK United States
- RPID United States
- Employees
- CIK N/A
- RPID N/A
- Industry
- CIK Finance/Investors Services
- RPID Medical Specialities
- Sector
- CIK Finance
- RPID Health Care
- Exchange
- CIK Nasdaq
- RPID Nasdaq
- Market Cap
- CIK 154.6M
- RPID 138.9M
- IPO Year
- CIK N/A
- RPID 2021
- Fundamental
- Price
- CIK $2.98
- RPID $3.36
- Analyst Decision
- CIK
- RPID Buy
- Analyst Count
- CIK 0
- RPID 1
- Target Price
- CIK N/A
- RPID $8.00
- AVG Volume (30 Days)
- CIK 115.4K
- RPID 78.6K
- Earning Date
- CIK 01-01-0001
- RPID 08-01-2025
- Dividend Yield
- CIK 9.03%
- RPID N/A
- EPS Growth
- CIK N/A
- RPID N/A
- EPS
- CIK N/A
- RPID N/A
- Revenue
- CIK N/A
- RPID $29,645,000.00
- Revenue This Year
- CIK N/A
- RPID $18.54
- Revenue Next Year
- CIK N/A
- RPID $20.55
- P/E Ratio
- CIK N/A
- RPID N/A
- Revenue Growth
- CIK N/A
- RPID 28.36
- 52 Week Low
- CIK $2.50
- RPID $0.63
- 52 Week High
- CIK $3.19
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- CIK 66.81
- RPID 48.28
- Support Level
- CIK $2.96
- RPID $3.45
- Resistance Level
- CIK $2.92
- RPID $3.62
- Average True Range (ATR)
- CIK 0.03
- RPID 0.21
- MACD
- CIK 0.00
- RPID -0.03
- Stochastic Oscillator
- CIK 92.86
- RPID 42.25
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.